Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Please indicate which comment is of concern and why. Your comments will be sent to our moderator for review.

Report comment to moderator

MandatoryRequired fields.

Headline

Why we should increase access of EHC to women, rather than restrict it

Comment

What interests me is that when you have 'POM to P' items, the wholesale price of the P item is always more (or the pack-size less) than the POM item. I don't remember this being the case with the 'Schedule 1' items of my younger days. Otherwise, we have the schemes where we are able to supply the item (with paperwork) for a few weeks, and then have to send the patient for proper medical consultation. Surely, if the purpose of 'POM to P' is to satisfy a need to stop people going to the doctor (as doctors are overloaded anyway), then there needs to be a more economical way for people to buy OTC items for IBS, or modern antacids, or whatever.

Posted date

1 SEP 2017

Posted time

14:24

Mandatory
Mandatory
Mandatory
Mandatory

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.